Eszopiclone treatment for insomnia: Effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 14, Issue 4, 2012, Pages

  Krystal, Andrew D ^a   McCall, W Vaughn ^b   Fava, Maurizio ^c   Joffe, Hadine ^c   Soares, Claudio N ^d   Huang, Holly ^e   Grinell, Todd ^e   Zummo, Jacqueline ^e   Spalding, William ^e   Marshall, Randall ^e  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d MCMASTER UNIVERSITY   (Canada)

^e DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESZOPICLONE; PLACEBO;

ADULT; AROUSAL; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EFFECT SIZE; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; INSOMNIA; INSOMNIA SEVERITY INDEX; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENOPAUSE; MULTICENTER STUDY (TOPIC); POSTMENOPAUSE; PRIMARY INSOMNIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOID ARTHRITIS; SLEEP DISORDER; SLEEP TIME;

EID: 84877969362     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.11m01296     Document Type: Article

References (54)

1. Roth T, Coulouvrat C, Hajak G, et al. Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey. Biol Psychiatry. 2011;69(6):592-600. PubMed doi:10.1016/j.biopsych.2010.10.023 ShowAbstract ShowAbstract
2. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. JPsychiatr Res. 1997;31(3):333-346. PubMed doi:10.1016/S0022-3956(97)00002-2 ShowAbstract ShowAbstract
3. Thase ME. Correlates and consequences of chronic insomnia. Gen Hosp Psychiatry. 2005;27(2):100-112. PubMed doi:10.1016/j.genhosppsych.2004.09.006 ShowAbstract ShowAbstract
4. Staner L. Comorbidity of insomnia and depression. Sleep Med Rev. 2010;14(1):35-46. PubMed doi:10.1016/j.smrv.2009.09.003 ShowAbstract ShowAbstract
5. Bassetti CL. Nonmotor disturbances in Parkinson's disease. Neurodegener Dis. 2011;8(3):95-108. PubMed doi:10.1159/000316613 ShowAbstract ShowAbstract
6. Louie GH, Tektonidou MG, Caban-Martinez AJ, et al. Sleep disturbances in adults with arthritis: prevalence, mediators, and subgroups at greatest risk: data from the 2007 National Health Interview Survey. Arthritis Care Res (Hoboken). 2011;63(2):247-260. PubMed doi:10.1002/acr.20362 ShowAbstract ShowAbstract
7. ME. Antidepressant treatment of the depressed patient with insomnia. JClin Psychiatry. 1999;60(suppl 17):28-31, discussion 46-48. PubMed ShowAbstract ShowAbstract
8. Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry. 2006;59(11):1052-1060. PubMed doi:10.1016/j.biopsych.2006.01.016 ShowAbstract ShowAbstract
9. Papadimitriou GN, Kerkhofs M, Kempenaers C, et al. EEG sleep studies in patients with generalized anxiety disorder. Psychiatry Res. 1988;26(2):183-190. PubMed doi:10.1016/0165-1781(88)90073-X ShowAbstract ShowAbstract
10. Stein MB, Roy-Byrne PP, Craske MG, et al. Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care. 2005;43(12):1164-1170. PubMed doi:10.1097/01.mlr.0000185750.18119.fd ShowAbstract ShowAbstract
11. Drewes AM, Nielsen KD, Hansen B, et al. A longitudinal study of clinical symptoms and sleep parameters in rheumatoid arthritis. Rheumatology (Oxford). 2000;39(11):1287-1289. PubMed doi:10.1093/rheumatology/39.11.1287 ShowAbstract ShowAbstract
12. Kirwan J, Heiberg T, Hewlett S, et al. Outcomes from the Patient Perspective Workshop at OMERACT 6. JRheumatol. 2003;30(4):868-872. PubMed ShowAbstract ShowAbstract
13. Dennerstein L, Dudley EC, Hopper JL, et al. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96(3):351-358. PubMed doi:10.1016/S0029-7844(00)00930-3 ShowAbstract ShowAbstract
14. Ohayon MM. Severe hot flashes are associated with chronic insomnia. Arch Intern Med. 2006;166(12):1262-1268. PubMed doi:10.1001/archinte.166.12.1262 ShowAbstract ShowAbstract
15. Taylor DJ, Lichstein KL, Durrence HH, et al. Epidemiology of insomnia, depression, and anxiety. Sleep. 2005;28(11):1457-1464. PubMed ShowAbstract ShowAbstract
16. Kaneita Y, Ohida T, Uchiyama M, et al. The relationship between depression and sleep disturbances: a Japanese nationwide general population survey. JClin Psychiatry. 2006;67(2):196-203. PubMed doi:10.4088/JCP.v67n0204 ShowAbstract ShowAbstract
17. Ohayon MM, Hong SC. Prevalence of major depressive disorder in the general population of South Korea. JPsychiatr Res. 2006;40(1):30-36. PubMed doi:10.1016/j.jpsychires.2005.02.003 ShowAbstract ShowAbstract
18. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA. 1989;262(11):1479-1484. PubMed doi:10.1001/jama.1989.03430110069030 ShowAbstract ShowAbstract
19. Breslau N, Roth T, Rosenthal L, et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39(6):411-418. PubMed doi:10.1016/0006-3223(95)00188-3 ShowAbstract ShowAbstract
20. McCall WV, Reboussin BA, Cohen W. Subjective measurement of insomnia and quality of life in depressed inpatients. JSleep Res. 2000;9(1):43-48. PubMed doi:10.1046/j.1365-2869.2000.00186.x ShowAbstract ShowAbstract
21. Roth T, Price JM, Amato DA, et al. The effect of eszopiclone in patients with insomnia and coexisting rheumatoid arthritis: a pilot study. Prim Care Companion J Clin Psychiatry. 2009;11(6):292-301. PubMed doi:10.4088/PCC.08m00749bro ShowAbstract ShowAbstract
22. Casper RC, Katz MM, Bowden CL, et al. The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine. JAffect Disord. 1994;31(3):151-164. PubMed doi:10.1016/0165-0327(94)90024-8 ShowAbstract ShowAbstract
23. McCall WV, Blocker JN, D'Agostino R Jr, et al. Insomnia severity is an indicator of suicidal ideation during a depression clinical trial. Sleep Med. 2010;11(9):822-827. PubMed doi:10.1016/j.sleep.2010.04.004 ShowAbstract ShowAbstract
24. Nierenberg AA, Petersen TJ, Alpert JE. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy. JClin Psychiatry. 2003;64(suppl 15):13-17. PubMed ShowAbstract ShowAbstract
25. Ferguson JM, Bielski RJ, Houston J, et al. Comparison of estazolam and placebo in the outpatient treatment of insomnia associated with major depression. Curr Ther Res Clin Exp. 1991;49(5):898-907.
26. Joffe H, Petrillo L, Viguera A, et al. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial. Am J Obstet Gynecol. 2010;202(2):171.e1-171.e11. PubMed doi:10.1016/j.ajog.2009.10.868 ShowAbstract ShowAbstract
27. Soares CN, Joffe H, Rubens R, et al. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. Obstet Gynecol. 2006;108(6):1402-1410. PubMed doi:10.1097/01.AOG.0000245449.97365.97 ShowAbstract ShowAbstract
28. Pollack M, Kinrys G, Krystal A, et al. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry. 2008;65(5):551-562. PubMed doi:10.1001/archpsyc.65.5.551 ShowAbstract ShowAbstract
29. Fava M, Asnis GM, Shrivastava R, et al. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. JClin Psychopharmacol. 2009;29(3):222-230. PubMed doi:10.1097/JCP.0b013e3181a390ba ShowAbstract ShowAbstract
30. Asnis GM, Chakraburtty A, DuBoff EA, et al. Zolpidem for persistent insomnia in SSRI-treated depressed patients. JClin Psychiatry. 1999;60(10):668-676. PubMed doi:10.4088/JCP.v60n1005 ShowAbstract ShowAbstract
31. Fava M, Asnis GM, Shrivastava RK, et al. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. JClin Psychiatry. 2011;72(7):914-928. PubMed doi:10.4088/JCP.09m05571gry ShowAbstract ShowAbstract
32. Scharf M. Eszopiclone for the treatment of insomnia. Expert Opin Pharmacother. 2006;7(3):345-356. PubMed doi:10.1517/14656566.7.3.345 ShowAbstract ShowAbstract
33. Walsh JK, Krystal AD, Amato DA, et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep. 2007;30(8):959-968. PubMed ShowAbstract ShowAbstract
34. Zammit GK, McNabb LJ, Caron J, et al. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr Med Res Opin. 2004;20(12):1979-1991. PubMed doi:10.1185/174234304X15174 ShowAbstract ShowAbstract
35. Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med. 1998;158(10):1099-1107. PubMed doi:10.1001/archinte.158.10.1099 ShowAbstract ShowAbstract
36. Feige B, Voderholzer U, Riemann D, et al. Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects. Neuropsychopharmacology. 2002;26(2):246-258. PubMed doi:10.1016/S0893-133X(01)00314-1 ShowAbstract ShowAbstract
37. Silvestri R, Pace-Schott EF, Gersh T, et al. Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal. JClin Psychiatry. 2001;62(8):642-652. PubMed doi:10.4088/JCP.v62n0812 ShowAbstract ShowAbstract
38. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric. 2001;4(4):267-272. PubMed ShowAbstract ShowAbstract
39. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297-307. PubMed doi:10.1016/S1389-9457(00)00065-4 ShowAbstract ShowAbstract
40. Groeger JA, Zijlstra FR, Dijk DJ. Sleep quantity, sleep difficulties and their perceived consequences in a representative sample of some 2000 British adults. JSleep Res. 2004;13(4):359-371. PubMed doi:10.1111/j.1365-2869.2004.00418.x ShowAbstract ShowAbstract
41. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1988
42. Roth T, Jaeger S, Jin R, et al. Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication. Biol Psychiatry. 2006;60(12):1364-1371. PubMed doi:10.1016/j.biopsych.2006.05.039 ShowAbstract ShowAbstract
43. Sivertsen B, Krokstad S, Øverland S, et al. The epidemiology of insomnia: associations with physical and mental health: the HUNT-2 study. JPsychosom Res. 2009;67(2):109-116. PubMed doi:10.1016/j.jpsychores.2009.05.001 ShowAbstract ShowAbstract
44. Terzano MG, Parrino L, Cirignotta F, et al; Studio Morfeo Committee. Studio Morfeo: insomnia in primary care, a survey conducted on the Italian population. Sleep Med. 2004;5(1):67-75. PubMed doi:10.1016/j.sleep.2003.09.006 ShowAbstract ShowAbstract
45. Budhiraja R, Roth T, Hudgel DW, et al. Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep. 2011;34(7):859-867. PubMed ShowAbstract ShowAbstract
46. Young T, Rabago D, Zgierska A, et al. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep. 2003;26(6):667-672. PubMed ShowAbstract ShowAbstract
47. Shin C, Lee S, Lee T, et al. Prevalence of insomnia and its relationship to menopausal status in middle-aged Korean women. Psychiatry Clin Neurosci. 2005;59(4):395-402. PubMed doi:10.1111/j.1440-1819.2005.01391.x ShowAbstract ShowAbstract
48. Poulin J, Chouinard S, Pampoulova T, et al. Sleep habits in middle-aged, non-hospitalized men and women with schizophrenia: a comparison with healthy controls. Psychiatry Res. 2010;179(3):274-278. PubMed doi:10.1016/j.psychres.2009.08.009 ShowAbstract ShowAbstract
49. Krystal AD, Erman M, Zammit GK, et al; ZOLONG Study Group. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep. 2008;31(1):79-90. PubMed ShowAbstract ShowAbstract
50. Xu M, Bélanger L, Ivers H, et al. Comparison of subjective and objective sleep quality in menopausal and non-menopausal women with insomnia. Sleep Med. 2011;12(1):65-69. PubMed doi:10.1016/j.sleep.2010.09.003 ShowAbstract ShowAbstract
51. Bourey RE. Primary menopausal insomnia: definition, review, and practical approach. Endocr Pract. 2011;17(1):122-131. PubMed doi:10.4158/EP08121.RA ShowAbstract ShowAbstract
52. National Institutes of Health. National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep. 2005;28(9):1049-1057. PubMed ShowAbstract ShowAbstract
53. Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. JClin Sleep Med. 2008;4(5):487-504. PubMed ShowAbstract ShowAbstract
54. Lu J, Greco MA. Sleep circuitry and the hypnotic mechanism of GABAA drugs. JClin Sleep Med. 2006;2(2):S19-S26. PubMed ShowAbstract ShowAbstract